The Oregon Health Authority (OHA) is anticipating 35,100 more doses of the Pfizer-BioNTech COVID-19 vaccines later this week.
The first vaccines arrived in Oregon on Monday and Tuesday and have been administered to high-risk health workers as well as staff and residents of long-term care facilities.
Additional Pfizer-BioNTech vaccine deliveries are scheduled to arrive in Oregon for the weeks of December 20 and December 27 — in allocations of 25,350 and 48,750, respectively.
As of midday today, at least 4,875 doses of the vaccine have been sent to Legacy Health, Oregon Health and Science University, Kaiser Permanente, and Saint Alphonsus. A total of 10,725 doses are being sent to pharmacies serving skilled nursing facilities as part of a federal partnership with CVS, Walgreens, and Consonus Healthcare. They will offer on-site, no-cost COVID-19 vaccines to staff and residents of more than 680 long term care facilities in Oregon.
If estimated allocations for Oregon are received, state health officials expect health systems will have a sufficient amount of vaccine to provide first doses to more than 100,000 health care workers and long term care facility residents by the end of the month.
- See also:
The Pfizer-BioNTech COVID-19 vaccine is a two-dose vaccine given 21 days apart. Clinical trial data show that the vaccine is 95% effective at preventing the COVID-19 infection starting seven days after the second dose. Individuals will not be considered fully protected until one to two weeks after they receive the second dose.
Pharmaceutical company Moderna submitted an EUA application on November 30, which will be reviewed on December 17. If the EUA is granted and the Moderna vaccine approved by the Scientific Safety Review Workgroup, around 103,600 doses of the Moderna vaccine should arrive by the end of December as well.
Both vaccines are currently only recommended for those aged 16 and over.